Bromodomain and extra-terminal (BET) family proteins: New therapeutic targets in major diseases

被引：0
作者：
Balasundaram Padmanabhan
Shruti Mathur
Ramu Manjula
Shailesh Tripathi
机构：
[1] National Institute of Mental Health and Neurosciences (NIMHANS),Department of Biophysics
来源：
Journal of Biosciences | 2016年 / 41卷
关键词：
BET family bromodomains; drug targets; epigenetics; structural biology; transcription regulation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The bromodomains and extra-terminal domain (BET) family proteins recognize acetylated chromatin through their bromodomains (BDs) and help in regulating gene expression. BDs are chromatin ‘readers’: by interacting with acetylated lysines on the histone tails, they recruit chromatin-regulating proteins on the promoter region to regulate gene expression and repression. Extensive efforts have been employed by scientific communities worldwide to identify and develop potential inhibitors of BET family BDs to regulate protein expression by inhibiting acetylated histone (H3/H4) interactions. Several small molecule inhibitors have been reported, which not only have high affinity but also have high specificity to BET BDs. These developments make BET family proteins an important therapeutic targets for major diseases such as cancer, neurological disorders, obesity and inflammation. Here, we review and discuss the structural biology of BET family BDs and their applications in major diseases.
引用
收藏
页码：295 / 311
页数：16
相关论文
共 334 条
[1]  
Alsarraj J(2012)Bromodomain-containing protein 4: a dynamic regulator of breast cancer metastasis through modulation of the extracellular matrix Int. J. Breast Cancer 2012 670632-596
[2]  
Hunter KW(2012)Fragment-based discovery of bromodomain inhibitors part 2: optimization of phenylisoxazole sulfonamides J. Med. Chem. 55 587-14537
[3]  
Bamborough P(2012)Selective inhibition of CD4+ T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitors Proc. Natl. Acad. Sci. 109 14532-477
[4]  
Diallo H(2012)BET domain co-regulators in obesity, inflammation and cancer Nat. Rev. Cancer 12 465-3678
[5]  
Goodacre JD(2013)BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses J. Immunol. 190 3670-6548
[6]  
Gordon L(2002)Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kB EMBO J. 21 6539-3838
[7]  
Lewis A(2011)Discovery and characterization of small molecule inhibitors of the BET family bromodomains J. Med. Chem. 54 3827-586
[8]  
Seal JT(2012)Fragment-based discovery of bromodomain inhibitors part 1: inhibitor binding modes and implications for lead discovery J. Med. Chem. 55 576-101
[9]  
Wilson DM(2004)Change in nuclear-cytoplasmic localization of double-bromodomain protein during proliferation and differentiation of mouse spinal cord and dorsal root ganglia Brain Res. Dev. Brain Res. 149 93-511
[10]  
Woodrow MD(2006)Identification of transcription complexes that contain the double bromodomain protein Brd2 and chromatin remodeling machines J. Proteome Res. 5 502-6549
12345678910